Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

被引：201

作者：

Phillips, Elizabeth J. ^{[1
]}

Sukasem, Chonlaphat ^{[2
,3
]}

Whirl-Carrillo, Michelle ^{[4
]}

Mueller, Daniel J. ^{[5
,6
]}

Dunnenberger, Henry M. ^{[7
]}

Chantratita, Wasun ^{[8
,9
]}

Goldspiel, Barry ^{[10
]}

Chen, Yuan-Tsong ^{[11
,12
]}

Carleton, Bruce C. ^{[13
,14
]}

George, Alfred L. ^{[15
]}

Mushiroda, Taisei ^{[16
]}

Klein, Teri ^{[4
]}

Gammal, Roseann S. ^{[17
,18
]}

Pirmohamed, Munir ^{[19
]}

机构：

[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Pharmacogen & Personalized Med,Dept Pathol, Bangkok, Thailand

[3] Ramathibodi Hosp, Fac Med, Somdech Phra Debaratana Med Ctr, Lab Pharmacogen, Bangkok, Thailand

[4] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA

[5] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada

[6] Univ Toronto, Dept Psychiat & Pharmacol & Toxicol, Toronto, ON, Canada

[7] NorthShore Univ HealthSyst, Ctr Mol Med, Evanston, IL USA

[8] Mahidol Univ, Ramathibodi Hosp, Fac Med, Virol Lab,Dept Pathol, Bangkok, Thailand

[9] Mahidol Univ, Ramathibodi Hosp, Ctr Med Genom, Bangkok, Thailand

[10] NIH, Pharm Dept, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA

[11] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan

[12] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA

[13] Univ British Columbia, Fac Med, Dept Pediat, Div Translat Therapeut, Vancouver, BC, Canada

[14] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada

[15] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA

[16] RIKEN, Ctr Integrat Med Sci, Lab Pharmacogen, Yokohama, Kanagawa, Japan

[17] MCPHS Univ, Dept Pharm Practice, Boston, MA USA

[18] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA

[19] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷 / 04期

基金：

英国医学研究理事会; 加拿大创新基金会; 加拿大健康研究院; 美国国家卫生研究院;

关键词：

STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; ADVERSE DRUG-REACTIONS; CYTOTOXIC T-CELLS; HLA-B-ASTERISK-1502; ALLELE; B GENOTYPE; HYPERSENSITIVITY REACTIONS; CUTANEOUS REACTIONS; JAPANESE PATIENTS; THAI POPULATION;

D O I：

10.1002/cpt.1004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The variant allele HLA-B*15:02 is strongly associated with greater risk of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in patients treated with carbamazepine or oxcarbazepine. The variant allele HLA-A*31:01 is associated with greater risk of maculopapular exanthema, drug reaction with eosinophilia and systemic symptoms, and SJS/TEN in patients treated with carbamazepine. We summarize evidence from the published literature supporting these associations and provide recommendations for carbamazepine and oxcarbazepine use based on HLA genotypes.

引用

页码：574 / 581

页数：8

共 40 条

[1] HLA-B locus in Caucasian patients with carbamazepine hypersensitivity [J].

Alfirevic, Ana ;

Jorgensen, Andrea L. ;

Williamson, Paula R. ;

Chadwick, David W. ;

Park, B. Kevin ;

Pirmohamed, Munir .

PHARMACOGENOMICS, 2006, 7 (06) :813-818

[2] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing [J].

Caudle, K. E. ;

Rettie, A. E. ;

Whirl-Carrillo, M. ;

Smith, L. H. ;

Mintzer, S. ;

Lee, M. T. M. ;

Klein, T. E. ;

Callaghan, J. T. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) :542-548

[3] Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population [J].

Chang, Choong-Chor ;

Too, Chun-Lai ;

Murad, Shahnaz ;

Hussein, Suraiya Hani .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (02) :221-224

[4] Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians [J].

Chen, Chun-Bing ;

Hsiao, Yi-Hsin ;

Wu, Tony ;

Hsih, Mo-Song ;

Tassaneeyakul, Wichittra ;

Jorns, Teekayu P. ;

Sukasem, Chonlaphat ;

Hsu, Chien-Ning ;

Su, Shih-Chi ;

Chang, Wan-Chun ;

Hui, Rosaline Chung-Yee ;

Chu, Chia-Yu ;

Chen, Yi-Ju ;

Wu, Ching-Ying ;

Hsu, Chao-Kai ;

Chiu, Tsu-Man ;

Sun, Pei-Lun ;

Lee, Hua-En ;

Yang, Chin-Yi ;

Kao, Pei-han ;

Yang, Chih-Hsun ;

Ho, Hsin-Chun ;

Lin, Jing-Yi ;

Chang, Ya-Ching ;

Chen, Ming-Jing ;

Lu, Chun-Wei ;

Ng, Chau Yee ;

Kuo, Kang-Ling ;

Lin, Chien-yio ;

Yang, Ching-Sheng ;

Chen, Ding-Ping ;

Chang, Pi-Yueh ;

Wu, Tsu-Lan ;

Lin, Yu-Jr ;

Weng, Yi-Ching ;

Kuo, Tseng-tong ;

Hung, Shuen-Iu ;

Chung, Wen-Hung .

NEUROLOGY, 2017, 88 (01) :78-86

[5] Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan [J].

Chen, Pei ;

Lin, Juei-Jueng ;

Lu, Chin-Song ;

Ong, Cheung-Ter ;

Hsieh, Peiyuan F. ;

Yang, Chih-Chao ;

Tai, Chih-Ta ;

Wu, Shey-Lin ;

Lu, Cheng-Hsien ;

Hsu, Yung-Chu ;

Yu, Hsiang-Yu ;

Ro, Long-Sun ;

Lu, Chung-Ta ;

Chu, Chun-Che ;

Tsai, Jing-Jane ;

Su, Yu-Hsiang ;

Lan, Sheng-Hsing ;

Sung, Sheng-Feng ;

Lin, Shu-Yi ;

Chuang, Hui-Ping ;

Huang, Li-Chen ;

Chen, Ying-Ju ;

Tsai, Pei-Joung ;

Liao, Hung-Ting ;

Lin, Yu-Hsuan ;

Chen, Chien-Hsiun ;

Chung, Wen-Hung ;

Hung, Shuen-Iu ;

Wu, Jer-Yuarn ;

Chang, Chi-Feng ;

Chen, Luke ;

Chen, Yuan-Tsong ;

Shen, Chen-Yang .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12) :1126-1133

[6] Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions [J].

Chen, Zhibin ;

Liew, Danny ;

Kwan, Patrick .

NEUROLOGY, 2014, 83 (22) :2077-2084

[7]

Silva Fabiano Pinheiro da, 2013, Rev. bras. ter. intensiva, V25, P284, DOI 10.5935/0103-507X.20130049

[8] Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis [J].

Das Ghosh, Damayanti ;

Mukhopadhyay, Indranil ;

Bhattacharya, Amrapali ;

Chowdhury, Rahul Roy ;

Mandal, Nidhu Ranjan ;

Roy, Sudipta ;

Sengupta, Sharmila .

INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) :2498-2508

[9] Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations [J].

Ferrell, P. Brent, Jr. ;

McLeod, Howard L. .

PHARMACOGENOMICS, 2008, 9 (10) :1543-1546

[10] Toxic epidermal necrolysis and Stevens-Johnson syndrome -: Does early withdrawal of causative drugs decrease the risk of death? [J].

Garcia-Doval, I ;

LeCleach, L ;

Bocquet, H ;

Otero, XL ;

Roujeau, JC .

ARCHIVES OF DERMATOLOGY, 2000, 136 (03) :323-327

← 1 2 3 4 →